Articles and posts USelectAllNewsPresentationsArticlesNeola Medical’s CEO shares more about the latest news in the spring investor letterMarch 20, 2024 | News, Non regulatoryCEO Hanna Sjöström visits a neonatal intensive care unit in the USAMarch 14, 2024 | Articles, NewsBioStock’s video podcast Health & Wealth invites CEO Hanna SjöströmMarch 13, 2024 | Articles, NewsNew research findings with Neola Medical’s technology published in the Journal of Biomedical OpticsMarch 11, 2024 | Articles, NewsBioStock in a new interview with CEO Hanna Sjöström about the usability study in the USAMarch 5, 2024 | Articles, NewsNeola Medical initiates Human Factors Validation Study in the USA ahead of FDA application for market approvalFebruary 29, 2024 | News, Non regulatoryNeola® is one of the finalists in Stanford’s Pitch Competition 2024February 26, 2024 | Articles, NewsCEO Hanna Sjöström comments the Q4 report of 2023 in BioStock studioFebruary 15, 2024 | NewsCEO and CFO presents the Q4 report of 2023February 15, 2024 | News, PresentationsNeola Medical Q4 report of 2023 – With a strengthened cash position, another show of strength is delivered through patent protection for future profitability driversFebruary 14, 2024 | News, RegulatoryThe strength of innovation from Skåne is being discussed with CEO Hanna Sjöström at MedInnovation 2024 at Medicon VillageFebruary 8, 2024 | Articles, NewsCEO Hanna Sjöström participates in the panel at Medtech Matchday 2024February 8, 2024 | Articles, News# 123456789101112131415161718192021222324252627 $ For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
Neola Medical’s CEO shares more about the latest news in the spring investor letterMarch 20, 2024 | News, Non regulatory
New research findings with Neola Medical’s technology published in the Journal of Biomedical OpticsMarch 11, 2024 | Articles, News
BioStock in a new interview with CEO Hanna Sjöström about the usability study in the USAMarch 5, 2024 | Articles, News
Neola Medical initiates Human Factors Validation Study in the USA ahead of FDA application for market approvalFebruary 29, 2024 | News, Non regulatory
Neola® is one of the finalists in Stanford’s Pitch Competition 2024February 26, 2024 | Articles, News
Neola Medical Q4 report of 2023 – With a strengthened cash position, another show of strength is delivered through patent protection for future profitability driversFebruary 14, 2024 | News, Regulatory
The strength of innovation from Skåne is being discussed with CEO Hanna Sjöström at MedInnovation 2024 at Medicon VillageFebruary 8, 2024 | Articles, News
CEO Hanna Sjöström participates in the panel at Medtech Matchday 2024February 8, 2024 | Articles, News